Sotera Health Company SHC
18.34
(0.11)
(0.60%)
as of 25 Sep
- Market cap
- $5.3B
- P/E
- 32.1×
Follow SHC
Growth Flags
show if company had growth for consecutive years
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | |
|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
65.33 | 91.20 | 93.06 | 0.00 | 56.07 | 0.00 | 4,648.15 | 4,648.15 | — |
P/S ratio |
4.30 | 3.52 | 4.49 | 2.32 | 7.06 | 8.50 | 7.32 | 7.32 | — |
P/FCF ratio |
33.58 | 85.79 | 0.00 | 24.41 | 36.66 | 103.69 | 37.18 | 37.18 | — |
P/Operating CF |
48.58 | 69.43 | 41.61 | 22.89 | 99.11 | 318.39 | 126.66 | 126.66 | — |
P/B ratio |
8.27 | 9.55 | 10.61 | 6.66 | 11.22 | 15.30 | 0.00 | 0.00 | — |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
EV/Sales |
5.93 | 5.37 | 6.34 | 3.92 | 8.87 | 10.66 | 10.94 | 10.94 | — |
EV/EBITDA |
13.68 | 12.61 | 15.00 | 9.62 | 19.97 | 24.15 | 24.81 | 24.81 | — |
EV/Operating CF |
24.02 | 26.35 | (45.04) | 14.17 | 29.35 | 72.34 | 35.18 | 35.18 | — |
EV/FCF |
46.23 | 131.01 | (18.34) | 41.20 | 46.07 | 130.05 | 55.56 | 55.56 | — |
Quick Ratio |
1.98 | 2.23 | 1.97 | 0.67 | 1.36 | 1.54 | 1.31 | 1.50 | — |
Current Ratio |
2.46 | 2.75 | 2.42 | 0.81 | 2.15 | 2.24 | 2.04 | 2.18 | — |
Net Debt/EBITDA |
3.74 | 4.35 | 4.39 | 3.92 | 4.08 | 4.90 | 8.22 | 7.51 | — |
Debt/Assets |
68.48% | 75.47% | 71.83% | 64.19% | 64.33% | 67.75% | 110.32% | 82.57% | 0.00% |
Debt/Equity |
3.69 | 5.73 | 5.07 | 5.71 | 3.06 | 4.12 | (4.44) | 49.16 | — |
Asset Turnover |
0.37 | 0.35 | 0.34 | 0.34 | 0.34 | 0.31 | 0.29 | 0.55 | — |
Operating CF/Net income |
3.68 | 5.06 | (2.89) | (1.19) | 2.41 | (3.12) | (7.15) | (20.37) | — |
Capex/Depreciation |
(0.97) | (1.05) | (1.29) | (1.13) | (0.65) | (0.34) | (0.37) | (0.36) | — |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| 15.42% | 10.45% | 12.87% | (49.89%) | 22.46% | 41.40% | 7.00% | 1.96% | — | |
| 2.46% | 1.43% | 1.64% | (7.91%) | 4.21% | (1.45%) | (0.79%) | (0.43%) | — | |
ROIC |
9.07% | 7.61% | 7.23% | 7.94% | 7.06% | 5.79% | 5.35% | 2.31% | — |
Return on Tangible Assets |
5.22% | 3.23% | 4.01% | (37.19%) | 13.99% | (4.92%) | (2.94%) | (0.78%) | — |
Average Days of Receivables |
46.21 | 48.75 | 53.37 | 47.49 | 44.21 | 50.64 | 46.56 | 57.65 | — |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
Selling, General and Administrative Expense of Revenue |
21.72% | 22.05% | 22.56% | 24.48% | 21.27% | 21.82% | 18.95% | 17.87% | — |
Intangible Assets out of Total Assets |
0.43 | 0.46 | 0.49 | 0.51 | 0.62 | 0.64 | 0.67 | 0.66 | 0.00 |
Share Based Compensation of Revenue |
2.65% | 3.34% | 3.07% | 2.11% | 1.49% | 1.34% | 0.88% | 0.93% | — |
Graham Net Nets |
(0.41) | (0.55) | (0.45) | (0.91) | (0.28) | (0.29) | 0.05 | 0.05 | — |
Graham Number |
3.60 | 2.20 | 2.53 | 0.00 | 4.45 | 0.00 | 0.00 | 0.00 | — |
Earnings Yield |
1.53% | 1.10% | 1.07% | (9.96%) | 1.78% | (0.53%) | 0.02% | 0.02% | — |
Free Cash Flow Yield |
2.98% | 1.17% | (7.71%) | 4.10% | 2.73% | 0.96% | 2.69% | 2.69% | — |
Revenue per Share |
4.10 | 3.89 | 3.73 | 3.58 | 3.34 | 3.44 | 3.35 | 3.21 | — |
Operating CF per Share |
1.01 | 0.79 | (0.53) | 0.99 | 1.01 | 0.51 | 0.64 | 0.51 | — |
Capex per Share |
(0.49) | (0.63) | (0.76) | (0.65) | (0.37) | (0.23) | (0.25) | (0.31) | — |
Free Cash Flow per Share |
0.53 | 0.16 | (1.29) | 0.34 | 0.64 | 0.28 | 0.39 | 0.20 | — |
Cash per Share |
1.22 | 0.99 | 1.07 | 1.41 | 0.38 | 0.43 | 0.27 | 0.42 | — |
Shareholders Equity per Share |
2.13 | 1.43 | 1.58 | 1.25 | 2.10 | 1.91 | (2.76) | 0.20 | — |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Book value per Share |
2.13 | 1.43 | 1.58 | 1.25 | 2.10 | 1.91 | (2.76) | 0.20 | — |
Free Cash Flow |
149.18 | 45.09 | (362.71) | 95.58 | 179.38 | 67.08 | 91.78 | 46.95 | — |
Working Capital |
363.83 | 335.04 | 326.59 | (146.56) | 184.80 | 174.42 | 128.36 | 169.49 | — |
Capital Expenditures |
(138.02) | (179.07) | (214.97) | (182.38) | (102.16) | (53.51) | (57.26) | (72.61) | — |
Net Current Asset Value |
(2,043.74) | (2,140.70) | (2,129.44) | (2,122.46) | (1,857.44) | (1,991.69) | (2,969.45) | (2,350.23) | — |
EV/EBIT |
19.05 | 19.85 | 24.05 | 15.86 | 32.19 | 42.34 | 0.00 | 0.00 | — |
Capex to Sales |
0.12 | 0.16 | 0.20 | 0.18 | 0.11 | 0.07 | 0.07 | 0.10 | — |
Net Profit Margin |
6.70% | 4.03% | 4.87% | (23.27%) | 12.55% | (4.72%) | (2.68%) | (0.79%) | — |
Price to Operating Income |
13.84 | 13.00 | 17.01 | 9.39 | 25.61 | 33.76 | 0.00 | 0.00 | — |
| Other line items | |||||||||
Depreciation/Fixed assets |
0.13 | 0.16 | 0.18 | 0.21 | 0.24 | 0.25 | 0.27 | 0.35 | — |
Cash ROIC |
(26.46%) | (27.07%) | (36.56%) | (18.07%) | (14.84%) | (20.15%) | (19.08%) | (19.63%) | — |
Accounts Receivable Turnover |
7.91 | 7.33 | 7.39 | 8.25 | 8.23 | 7.69 | 7.17 | 5.88 | — |
Accounts Payable Turnover |
7.79 | 7.90 | 6.50 | 6.08 | 6.59 | 7.94 | 8.67 | 8.84 | — |
Inventory Turnover |
10.01 | 10.22 | 11.05 | 9.77 | 9.34 | 10.48 | 10.21 | 9.72 | — |
Average Days of Payables |
54.93 | 40.37 | 54.92 | 60.58 | 64.43 | 51.06 | 40.04 | 43.51 | — |
Days of Inventory on Hand |
38.31 | 36.02 | 37.35 | 30.35 | 48.00 | 33.22 | 35.65 | 35.29 | — |
Average Receivables |
147.16 | 150.21 | 142.00 | 121.70 | 113.17 | 106.40 | 108.57 | 127.00 | — |
Average Payables |
66.53 | 63.07 | 72.59 | 73.50 | 62.63 | 47.20 | 44.18 | 44.00 | — |
Average Inventory |
51.77 | 48.74 | 42.73 | 45.72 | 44.19 | 35.74 | 37.50 | 40.00 | — |
Average Assets |
3,167.42 | 3,101.03 | 3,124.06 | 2,953.60 | 2,775.39 | 2,670.98 | 2,644.63 | 1,354.29 | — |
Average Common Equity |
505.47 | 424.32 | 396.99 | 468.17 | 520.34 | (93.28) | (297.82) | (299.50) | — |
Columns are period end dates